{
  "ticker": "ZYME",
  "company_name": "Zymeworks Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT06523803",
      "title": "A Study of ZW171 in Participants With Advanced or Metastatic Mesothelin-expressing Cancers",
      "status": "TERMINATED",
      "phase": "PHASE1",
      "condition": "Mesothelin-expressing Advanced Cancers",
      "start_date": "2024-09-30",
      "completion_date": "2025-10-01",
      "enrollment": 0,
      "sponsor": "Zymeworks BC Inc."
    },
    {
      "nct_id": "NCT04513665",
      "title": "ZW25 in Women With Endometrial Cancers",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Endometrial Cancer, Carcinosarcoma",
      "start_date": "2020-08-12",
      "completion_date": "2024-03-08",
      "enrollment": 0,
      "sponsor": "Memorial Sloan Kettering Cancer Center"
    },
    {
      "nct_id": "NCT06555744",
      "title": "A Study of ZW191 in Participants With Solid Tumors",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Advanced Solid Tumors",
      "start_date": "2024-10-30",
      "completion_date": "2027-01",
      "enrollment": 0,
      "sponsor": "Zymeworks BC Inc."
    },
    {
      "nct_id": "NCT05615818",
      "title": "Personalized Medicine for Advanced Biliary Cancer Patients",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "Biliary Tract Neoplasms",
      "start_date": "2024-07-18",
      "completion_date": "2028-06",
      "enrollment": 0,
      "sponsor": "UNICANCER"
    },
    {
      "nct_id": "NCT03821233",
      "title": "A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "HER2-expressing Cancers",
      "start_date": "2019-04-15",
      "completion_date": "2024-10-08",
      "enrollment": 0,
      "sponsor": "Zymeworks BC Inc."
    },
    {
      "nct_id": "NCT07164313",
      "title": "A Study of ZW251 in Participants With Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Hepatocellular Carcinoma",
      "start_date": "2025-10-21",
      "completion_date": "2028-05",
      "enrollment": 0,
      "sponsor": "Zymeworks BC Inc."
    },
    {
      "nct_id": "NCT05035836",
      "title": "A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC)",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Breast Cancer, HER2-positive",
      "start_date": "2021-11-16",
      "completion_date": "2028-12-29",
      "enrollment": 0,
      "sponsor": "M.D. Anderson Cancer Center"
    }
  ],
  "summary": {
    "total_trials": 7,
    "by_phase": {
      "PHASE1": 4,
      "PHASE2": 2,
      "PHASE3": 1
    },
    "by_status": {
      "TERMINATED": 1,
      "COMPLETED": 2,
      "RECRUITING": 4
    },
    "active_trials": 4,
    "completed_trials": 2,
    "conditions": [
      "Advanced Solid Tumors",
      "Biliary Tract Neoplasms",
      "Breast Cancer, HER2-positive",
      "Endometrial Cancer, Carcinosarcoma",
      "HER2-expressing Cancers",
      "Hepatocellular Carcinoma",
      "Mesothelin-expressing Advanced Cancers"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:23:07.524755",
    "search_query": "Zymeworks Inc.",
    "url": "https://clinicaltrials.gov/search?term=Zymeworks+Inc."
  }
}